A review of current research on the effect of diabetes mellitus on the eye

REFERENCES

• Mitchell P., Smith W., Wang JJ, Attebo KA. Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. Ophthalmology 1998; 105: 406–411.
   PubMed Web of Science ®Google Scholar
• Mccarty CA, Lloyd smith CW, Livingston PM, Stanislavsky YL, Taylor HR. Use of eye care services by people with diabetes: The Melbourne Visual Impairment Project. Brit J Ophthalmol 1998; 82: 410–414.
   PubMed Web of Science ®Google Scholar
• Mcgwin G., Sims RV, Pulley LV, Roseman JM. Diabetes and automobile crashes in the elderly. A population‐based case‐control study. Diabetes Care 1999; 22: 220–227.
   Web of Science ®Google Scholar
• Klein R., Klien BEK, Moss SE, Cruickshank KJ. The Winsconsin epidemiological study of diabetic retinopathy: XVII. Ophthalmology 1998; 105: 1801–1815.
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetics. BMJ 1998; 317: 703–713.
   PubMed Web of Science ®Google Scholar
• Lobefalo L., Verrotti A., Mastropasqua L., Chiarelli F., Morgese G., Gallenga PE. Flicker perimetry in diabetic children without retinopathy. Can J Ophthalmol 1997; 32: 324–328.
   PubMed Web of Science ®Google Scholar
• Evans PM, Purewal TS, Hopper A., Slater H., Jones DR, O'hare JP. Screening for diabetic retinopathy in primary care: retinal photography alone can be used efficiently and effectively to exclude those with sight threatening lesions. J Med Screen 1997: 174–176.
   Google Scholar
• Hellstedt T., Kaaja R., Teramo K., Immonen I. Contrast sensitivity in diabetic pregnancy. Graefes Arch Clin Exp Ophthalmol 1997; 235: 70–75.
   Web of Science ®Google Scholar
• Hansson lundblad C., Agardh E., Agardh CD. Retinal examination intervals in diabetic patients on diet treatment only. Acta Ophthalmol Scand 1997; 75: 244–248.
   Google Scholar
• Tsujikawa A., Otani A., Takanashi T., Ogura Y. Long‐term prognosis of extracapsular cataract extraction and intraocular lens implantation in diabetic patients. Jpn J Ophthalmol 1997; 41: 319–323.
   Web of Science ®Google Scholar
• Raniel Y., Teichner Y. [Progression of diabetic retinopathy after cataract extraction.] Friedman Z Harefuah 1998; 134: 3–6.
   Google Scholar
• Mitchell P., Smith W., Chey T., Healey PR. Open‐angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology 1997; 104: 712–718.
   PubMed Web of Science ®Google Scholar
• Konstas AG, Tsatsos I., Kardasopoulos A., Bufidis T., Maskaleris G. Preoperative features of patients with exfoliation glaucoma and primary open‐angle glaucoma. The AHEPA study. Acta Ophthalmol Scand 1998; 76: 208–212.
   Google Scholar
• Georgopoulos G., Andreanos D., Liokis N., Papakonstantinou D., Vergados J., Theodossiadis G. Risk factors in ocular hypertension. Eur J Ophthalmol 1997; 7: 357–363.
   PubMedGoogle Scholar
• North RV, Cooney O., Chambers D., Dolben J., Owens DR. Does hyperglycaemia have an influence upon colour vision of patients with diabetes mellitus? Ophthalmic Physiol Opt 1997; 17:95–101.
   Web of Science ®Google Scholar
• Kurtenbach A., Schiefer U., Neu A., Zrenner E. Preretinopic changes in the colour vision ofjuvenile diabetics. Brit J Ophthalmol 1999; 83: 443–446.
   Web of Science ®Google Scholar
• Ismail GM, Whitaker D. Early detection of changes in visual function in diabetes mellitus. Ophthalmic Physiol Opt 1998; 8: 3–12.
   Google Scholar
• Schneck ME, Fortune B., Switkes E., Crognale M., Adams AJ. Acute effects of blood glucose on chromatic visually evoked potentials in persons with diabetes and in normal persons. Invest Ophthalmol Vis Sci 1997; 38: 800–810.
   Web of Science ®Google Scholar
• Yamamoto S., Kamiyama M., Nitta K., Yamada T., Hayasaka S. Selective reduction of the S cone electroretinogram in diabetes. Brit J Ophthalmol 1996; 80: 973–975.
   Web of Science ®Google Scholar
• Yamamoto S., Takeuchi S., Kamiyama M. The short wavelength‐sensitive cone electroretinogram in diabetes: relationship to systemic factors. Doc Ophthalmol 199798; 94: 193–200.
   Web of Science ®Google Scholar
• Tregear SJ, Knowles PJ, Ripley LG, Casswell AG. Chromatic contrast threshold impairment in diabetes. Eye 1997; 11: 537–546.
   Web of Science ®Google Scholar
• Sanchez thorin JC. The cornea in diabetes mellitus. Int Ophthalmol Clin 1998; 38: 19–36.
   Google Scholar
• Ishiko S., Yoshida A., Mori F., Abiko T., Kitaya N., Kojima M., Saito K. [Early ocular changes in a tree shrew model of diabetes.] Nippon Ganka Gakkai Zasshi 1997; 101: 19–23.
   Google Scholar
• Ishiko S., Yoshida A., Mori F., Abiko T., Kitaya, Konno S. N., Kato Y. Corneal and lens autofluorescence in young insulin‐dependent diabetic patients. Ophthalmologica 1998; 212: 301–305.
   Web of Science ®Google Scholar
• Mori F., Ishiko S., Abiko T., Kitaya N., Kato Y., Kanno H., Yoshida A. Changes in corneal and lens autofluorescence and blood glucose levels in diabetics: parameters of blood glucose control. Curr Eye Res 1997; 16: 534–538.
   PubMed Web of Science ®Google Scholar
• Jacot JL, Hosotani H., Glover JP, Lois N., Robison WG Jr. Diabetic‐like corneal sensitivity loss in galactose‐fed rats ameliorated with aldose reductase inhibitors. J Ocul Pharmacol Ther 1998; 14: 169–180.
   Web of Science ®Google Scholar
• Nakamura M., Sato N., Chikama TI, Hasegawa Y., Nishida T. Hyaluronan facilitates corneal epithelial wound healing in diabetic rats. Exp Eye Res 1997; 64: 1043–1050.
   PubMed Web of Science ®Google Scholar
• Saini JS, Mittal S., Anand M. Cornea stress test‐evaluation of corneal endothelial function in vivo by contact lens induced stress. Indian J Ophthalmol 1997; 45: 19–24.
   Google Scholar
• Mcnamara NA, Brand RJ, Polse KA, Bourne WM. Corneal function during normal and high serum glucose levels in diabetes. Invest Ophthalmol Vis Sci 1998; 39: 3–17.
   PubMed Web of Science ®Google Scholar
• Cunha vaz JG. The blood‐ocular barriers: past, present and future. Doc Ophthalmol 1997; 93: 149–157.
   Web of Science ®Google Scholar
• Hashimoto H. [The role of glycation in cataract lens in diabetic patients.] Nippon Ganka Gakkai Zasshi 1998; 102: 34–41.
   Google Scholar
• Hinkelmann L., Struck HG, Lautenschlager C. [Inflammatory reaction of the anterior eye segment. Cataract extraction in patients with and without diabetes mellitus.] Ophthalmologe 1998; 95: 213–218.
   Web of Science ®Google Scholar
• Wiedemann R., Walter A., Wiedemann P. [Tyndallometry in patients with diabetic macular edema before and after central laser coagulation.] Klin Monatsbl Augenheilkd 1998; 212: 32–36.
   Web of Science ®Google Scholar
• Mester U., Strauss M., Grewing R. Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. J Cat Refract Surg 1998; 24: 380–384.
   PubMed Web of Science ®Google Scholar
• Blum M., Müller UA, Hoche A., Hunger dathe W., Stein G., Strobel J. [Flare measurement and albuminuria in type I diabetics.] Klin Monatsbl Augenheilkd 1998; 212: 80–83.
   Web of Science ®Google Scholar
• Zaczek A., Zetterstrom C. The effect of phenylephrine and pilocarpine on pupil size and aqueous flare intensity in patients with diabetes mellitus. Acta Ophthalmol Scand 1998; 76: 413–416.
   Google Scholar
• Chakrabarti S., Sima AA. Endothelin‐1 and endothelin‐3‐like immunoreactivity in the eyes of diabetic and non‐diabetic BB/Wrats. Diabetes Res Clin Pract 1997; 37: 109–120.
   PubMed Web of Science ®Google Scholar
• Wollensak G., Schaefer HE, Ihling C. An immunohistochemical study of endothelin‐1 in the human eye. Curr Eye Res 1998; 17: 541–545.
   PubMed Web of Science ®Google Scholar
• Ripodas A., De Juan JA, Moya FJ, Fernandez cruz A., Fernandez durango R. Identification of endothelin receptor subtypes in rat ciliary body using subtype‐selective ligands. Exp Eye Res 1998; 66: 69–79.
   Web of Science ®Google Scholar
• Sabasinski K. [The role of polyol pathways in formation of diabetic cataracts.] Andrzejewska Buczko J Klin Oczna 1997; 99: 401–404.
   Google Scholar
• Siman M. Congenital malformations in experimental diabetic pregnancy: aetiology and antioxidative treatment. Mini‐review based on a doctoral thesis. Ups J Med Sci 1997; 102: 61–98.
   Google Scholar
• Miyamura N., Amemiya T. Lens and retinal changes in the WBN/Kob rat (spontaneously diabetic strain). Electron microscopic study. Ophthalmic Res 1998; 30: 221–232.
   Web of Science ®Google Scholar
• Struck HG, Hammer U., Seydewitz V. [Effect of diabetes mellitus on anterior central lens epithelium in cataract patients.] Ophthalmologe 1997; 94: 327–331.
   Web of Science ®Google Scholar
• Stevens A. Contribution of glucose and its metabolites to diabetic cataracts. Clin Exp Optom 1993; 76: 208–214.
   Google Scholar
• Harding JJ. Aldose reductase (or is it?). TIBS 1993; 494.
   Google Scholar
• Wilson DK, Bohren KM, Gabba KH, Quiocho FA. An unlikely sugar substrate site in the 1.65 Å structure of the human aldose reductase holoenzyme implicated in diabetic complications. Science 1992; 257: 81–84.
   PubMed Web of Science ®Google Scholar
• Ashizawa N., Yoshida M., Sugiyama Y., Akaike N., Ohbayashi S., Aotsuka T., Abe N., Fukushima K., Matsuura A. Effects of a novel potent aldose reductase inhibitor, GP‐1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats. Jpn J Pharmacol 1997; 73: 133–144.
   PubMedGoogle Scholar
• Horie S., Nagai H., Yuuki T., Narita Y., Tsuda Y., Nakajima T., Nakamura N. Effect of SG‐210, a novel aldose reductase inhibitor, on impaired polyol pathway in rats received diabetic manipulations. J Diab Complic 1998; 12: 163–169.
   Google Scholar
• Cameron NE, Cotter MA, Basso M., Hohman TC. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin‐diabetic rats. Diabetologia 1997; 40: 271–281.
   Web of Science ®Google Scholar
• Hashimoto H., Arai K., Yoshida S., Chikuda M., Obara Y. Pentosidine and autofluorescence in lenses of diabetic patients. Jpn J Ophthalmol 1997; 41: 274–277.
   Web of Science ®Google Scholar
• Ahmed MU, Brinkmann frye E., Degenhardt TP, Thorpe SR, Baynes JW. N‐epsilon‐(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 1997; 324: 565–570.
   PubMed Web of Science ®Google Scholar
• Stevens A. The contribution of glycation to cataract formation in diabetes. J Amer Optom Assoc 1998; 69: 519–530.
   PubMedGoogle Scholar
• Matsumoto K., Ikeda K., Horiuchi S., Zhao H., Abraham EC. Immunochemical evidence for increased formation of advanced glycation end products and inhibition by aminoguanidine in diabetic rat lenses. Biochem Biophys Res Commun 1997; 241: 352–354.
   PubMed Web of Science ®Google Scholar
• Varma SD, Devamanoharan PS, Ali AH. Formation of advanced glycation end (AGE) products in diabetes: prevention by pyruvate and alpha‐keto glutarate. Mol Cell Biochem 1997; 171: 23–28.
   PubMed Web of Science ®Google Scholar
• Pessotto P., Liberati R., Petrella O., Romanelli L., Calvani M., Peluso G. In experimental diabetes the decrease in the eye of lens carnitine levels is an early important and selective event. Exp Eye Res 1997; 64: 195–201.
   Web of Science ®Google Scholar
• Altomare E., Grattagliano I., Vendemaile G., Micelli ferrari T., Signorile A., Cardia L. Oxidative protein damage in human diabetic eye: evidence of a retinal participation. Eur J Clin Invest 1997; 27: 141–147.
   PubMed Web of Science ®Google Scholar
• Mitton KP, Trevithick JR. High performance liquid chromatography‐electrochemical detection of antioxidants in vertebrate lens: glutathione, tocopherol, and ascorbate. Methods Enzymol 1994; 233: 523–539.
   PubMed Web of Science ®Google Scholar
• Mitton KP, Dzialoszynski T., Sanford SE, Trevithick JR. Cysteine and ascorbate loss in the diabetic rat lens prior to hydration changes. Curr Eye Res 1997; 16: 564–571.
   PubMed Web of Science ®Google Scholar
• Ozmen D., Mutaf I., Ozmen B., Mentes J., Bayindir O. Lens lipid peroxides and glutathione concentrations in diabetic cataract. Ann Clin Biochem 1997; 34: 190–192.
   PubMed Web of Science ®Google Scholar
• Lin J. Pathophysiology of cataracts: copper ion and peroxidation in diabetics. Jpn J Ophthalmol 1997; 41: 130–137.
   Web of Science ®Google Scholar
• Crabbe MJ, Goode D. Aldose reductase: a window to the treatment of diabetic complications? Prog Retin Eye Res 1998; 17: 313–383.
   PubMed Web of Science ®Google Scholar
• Khanna P., Wang L., Perez polo RJ. Ansari NH. Oxidative defense enzyme activity and mRNA levels in lenses of diabetic rats. J Toxicol Environ Health 1997; 51: 541–555.
   PubMed Web of Science ®Google Scholar
• Cekic O., Bardak Y. Lenticular calcium, magnesium, and iron levels in diabetic rats and verapamil effect. Ophthalmic Res 1998; 30: 107–112.
   PubMed Web of Science ®Google Scholar
• Hook DW, Harding J. Inactivation of glyceraldehyde 3‐phosphate dehydrogenase by sugars, prednisolone‐21‐hemisuccinate, cyanate and other small molecules. J Biochim Biophys Acta 1997; 1362: 232–242.
   Web of Science ®Google Scholar
• Hook DW, Harding JJ. Protection of enzymes by alpha‐crystallin acting as a molecular chaperone. Int J Biol Macromol 1998; 22: 295–306.
   Web of Science ®Google Scholar
• Deguine V., Labat robert J., Ferrari P., Pouliquen Y., Menasche M., Robert L. [Ageing of the vitreous body. Role of glycation and free radicals.] Pathol Biol Paris 1997; 45: 321–330.
   Google Scholar
• Dunker S., Kleinert R., Faulborn J. [Immunohistologic studies of the vitreous humor.] Ophthalmologe 1998; 95: 8–12.
   Google Scholar
• Jager J., Tromp A., Hooymans JM, Reitsma WD, Smit AJ. Reproducibility of vitreous fluorophotometry in patients with type 1 diabetes mellitus. Ophthalmologica 1997; 211: 209–213.
   Web of Science ®Google Scholar
• Nuzzi G., Venturini I., De Gregorio M., Arsenio L., Maraini G. Vitreous fluorophotometry and changes in blood‐retinal barrier permeability induced by bendazac lysine. Acta Ophthalmol Scand 1997; 75: 41–43.
   Google Scholar
• Cunha vaz J., Lobo C., Sousa JC, Oliveiros B., Leite E., De Abreu JR. Progression of retinopathy and alteration of the blood‐retinal barrier in patients with type 2 diabetes: a 7‐year prospective follow‐up study. Graefes Arch Clin Exp Ophthalmol 1998; 236: 264–268.
   Web of Science ®Google Scholar
• Heegaard S. Structure of the vitreoretinal border region in spontaneously diabetic BB rats. Acta Ophthalmol Copenh 1993; 71: 637–644.
   Web of Science ®Google Scholar
• Ambati J., Chalam KV, Chawla DK, D'angio CT, Guillet EG, Rose SJ, Vanderlinde RE, Ambati BK. Elevated gamma‐aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1997; 115: 1161–1166.
   PubMed Web of Science ®Google Scholar
• Burgos R., Simo R., Audi L., Mateo C., Mesa J., Garcia ramirez M., Carrascosa A. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Diabetologia 1997; 40: 1107–1109.
   PubMed Web of Science ®Google Scholar
• Pfeiffer A., Spranger J., Meyer schwickerath R., Schatz H. Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown. Diabetes 1997; 46 (suppl 2): S26–30.
   Google Scholar
• Ogata M., Naruse M., Iwasaki N., Katoh S., Ohta Y., Hori S., Demura H., Iwamoto Y. Immunoreactive endothelin levels in the vitreous fluid are decreased in diabetic patients with proliferative retinopathy. J Cardiovasc Pharmacol 1998; 31 (suppl 1): S378–379.
   Google Scholar
• Deguine delay V., Menasche M., Schaeverbeke M., Schaeverbeke J., Pouliquen Y., Robert L. [Epigenetic mechanisms of aging: relations between Maillard reactions and radical generation.. CR Seances Soc Biol Fil 1997; 191: 247–252.
   Google Scholar
• Deguine V., Menasche M., Ferrari P., Fraisse L., Pouliquen Y., Robert L. Free radical depolymerization of hyaluronan by Maillard reaction products: role in liquefaction of aging vitreous. Int J Biol Macromol 1998; 22: 17–22.
   PubMed Web of Science ®Google Scholar
• Alder VA, Su EN, Yu DY, Cringle SJ, Yu PK. Diabetic retinopathy; early functional changes. Clin Exp Pharmacol Physiol 1997; 24: 785–788.
   Web of Science ®Google Scholar
• Ruggiero D., Lecomte M., Michoud E. Lagarde M. Involvement of cell‐cell interactions in the pathogenesis of diabetic retinopathy. Wiernsperger N Diabetes Metab 1997; 23: 30–42.
   PubMed Web of Science ®Google Scholar
• Miyamura N., Amemiya T. Lens and retinal changes in the WBN/Kob rat (spontaneously diabetic strain). Electron microscopic study. Ophthalmic Res 1998; 30: 221–232.
   Web of Science ®Google Scholar
• Bollineni JS, Alluru I., Reddi AS. Heparan sulfate proteoglycan synthesis and its expression are decreased in the retina of diabetic rats. Curr Eye Res 1997; 16: 127–130.
   PubMed Web of Science ®Google Scholar
• Krasnov MM, Sdobnikova SV, Fedorov AA, Stoliarenko GE. [Posterior hyaloid membrane as structural base of growth of neovascular tissue in proliferative diabetic retinopathy.. Vestn Oftalmol 1998; 114: 16–20.
   Google Scholar
• Mizutani M., Gerhardinger C., Lorenzi M. Müller cell changes in human diabetic retinopathy. Diabetes 1998; 47: 445–449.
   PubMed Web of Science ®Google Scholar
• Holopigian K., Greenstein VC, Seiple W., Hood DC, Carr RE. Evidence for photoreceptor changes in patients with diabetic retinopathy. Invest Ophthalmol Vis Sci 1997; 38: 2355–2365.
   PubMed Web of Science ®Google Scholar
• Naeser P. Insulin receptors in human ocular tissues. Immunohistochemical demonstration in normal and diabetic eyes. Ups J Med Sci 1997; 102: 35–40.
   Web of Science ®Google Scholar
• Deschenes MC, Coupland SG, Ross SA, Fick GH. Early macular dysfunction detected by focal electroretinographic recording in non‐insulin‐dependent diabetics without retinopathy. Doc Ophthalmol 199798; 94: 223–237.
   Web of Science ®Google Scholar
• Ellis EA, Grant MB, Murray FT, Wachowski MB, Guberski DL, Kubilis PS, Lutty GA. Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 1998; 24: 111–120.
   PubMed Web of Science ®Google Scholar
• Kristinsson JK, Gottfredsdottir MS, Stefansson E. Retinal vessel dilatation and elongation precedes diabetic macular oedema. Brit J Ophthalmol 1997; 81: 274–278.
   PubMed Web of Science ®Google Scholar
• Schmetterer L., Salomon A., Rheinberger A. Unfried C, Lexer F, Wolzt M. Fundus pulsation measurements in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 1997; 235: 283–287.
   Web of Science ®Google Scholar
• Kunisaki M., Bursell SE, Umeda F., Nawata H., King GL. Prevention of diabetes‐induced abnormal retinal blood flow by treatment with d‐alpha‐tocopherol. Biofactors 1998; 7: 55–67.
   PubMed Web of Science ®Google Scholar
• Preissner KT, Kanse SM, Hammes HP. Integrin chatter and vascular function in diabetic retinopathy. Horm Metab Res 1997; 29: 643–645.
   PubMed Web of Science ®Google Scholar
• Hirata C., Nakano K., Nakamura N., Kitagawa Y., Shigeta H., Hasegawa G., Ogata M., Ikeda T., Sawa H., Nakamura K., Ienaga K., Obayashi H., Kondo M. Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Müller cells. Biochem Biophys Res Commun 1997; 236: 712–715.
   PubMed Web of Science ®Google Scholar
• Soulis T., Thallas V., Youssef S., Gilbert RE, Mcwilliam BG, Murray mcintosh RP, Cooper ME. Advanced glycation end products and their receptors co‐localise in rat organs susceptible to diabetic microvascular injury. Diabetologia 1997; 40: 619–628.
   PubMed Web of Science ®Google Scholar
• Clements RS Jr, Robison WG Jr, Cohen MP. Anti glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice. J Diab Complic 1998; 12: 28–33.
   Google Scholar
• Hammes HP, Wellensiek B., Kloting I., Sickel E., Bretzel RG, Brownlee M. The relationship of glycaemic level to advanced glycation end‐product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster. Diabetologia 1998; 41: 165–170.
   PubMed Web of Science ®Google Scholar
• Grattagliano I., Vendemiale G., Boscia F., Micelli ferrari T., Cardia L., Altomare E. Oxidative retinal products and ocular damages in diabetic patients. Free Radic Biol Med 1998; 25: 369–372.
   PubMed Web of Science ®Google Scholar
• Sharpe PC, Liu WH, Yue KK, Mcmaster D., Catherwood MA, Mcginty AM, Trimble ER. Glucose induced oxidative stress in vascular contractile cells: comparison of aortic smooth muscle cells and retinal pericytes. Diabetes 1998; 47: 801–809.
   PubMed Web of Science ®Google Scholar
• Agardh CD, Agardh E., Hultberg B., Qian Y., Ostenson CG. The glutathione levels are reduced in Goto‐Kakizaki rat retina, but are not influenced by aminoguanidine treatment. Curr Eye Res 1998; 17: 251–256.
   PubMed Web of Science ®Google Scholar
• Salceda R., Vilchis C., Coffe V., Hernandez munoz R. Changes in the redox state in the retina and brain during the onset of diabetes in rats. Neurochem Res 1998; 23: 893–897.
   Web of Science ®Google Scholar
• Yu PH. Deamination of methylamine and angiopathy, toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes. J Neural Transm (suppl) 1998; 52: 201–216.
   Google Scholar
• Ansari NH, Zhang W., Fulep E., Mansour A. Prevention of pericyte loss by trolox in diabetic rat retina. J Toxicol Environ Health 1998; 54: 467–475.
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Kern TS, Engerman RL. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Radic Biol Med 1997; 22: 587–592.
   PubMed Web of Science ®Google Scholar
• Giardino I., Fard AK, Hatchell DL, Brownlee M. Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant‐induced apoptosis. Diabetes 1998; 47: 1114–1120.
   PubMed Web of Science ®Google Scholar
• Hammes HP, Bartmann A., Engel L. Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine. Wulfroth P Diabetologia 1997; 40: 629–634.
   PubMed Web of Science ®Google Scholar
• Clermont AC, Aiello LP, Mori F., Aiello LM, Bursell SE. Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Amer J Ophthalmol 1997; 124: 433–446.
   PubMed Web of Science ®Google Scholar
• Sone H., Kawakami Y., Okuda Y., Sekine Y., Honmura S., Matsuo K., Segawa T., Suzuki H., Yamashita K. Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes. Diabetologia 1997; 40: 726–730.
   PubMed Web of Science ®Google Scholar
• Gilbert RE, Vranes D., Berka JL, Kelly DJ, Cox A., Wu LL, Stacker SA, Cooper ME. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab Invest 1998; 78: 1017–1027.
   PubMed Web of Science ®Google Scholar
• Boulton M., Foreman D., Williams G., Mcleod D. VEGF localisation in diabetic retinopathy. Brit J Ophthalmol 1998; 82: 561–568.
   PubMed Web of Science ®Google Scholar
• Murata T., Nakagawa K., Khalil A., Ishibashi T., Inomata H., Sueishi K. The relation between expression of vascular endothelial growth factor and breakdown of the blood‐retinal barrier in diabetic rat retinas. Lab Invest 1996; 74:819–825.
   PubMed Web of Science ®Google Scholar
• Amin RH, Frank RN, Kennedy A., Eliott D., Puklin JE, Abrams GW. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1997; 38: 36–47.
   PubMed Web of Science ®Google Scholar
• Gerhardinger C., Brown LF, Roy S., Mizutani M., Zucker CL, Lorenzi M. Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. Amer J Pathol 1998; 152: 1453–1462.
   PubMed Web of Science ®Google Scholar
• Aiello LP, Bursell SE, Clermont A., Duh E., Ishii H., Takagi C., Mori F., Ciulla TA, Ways K., Jirousek M., Smith LE, King GL. Vascular endothelial growth factor‐induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta‐isoform‐selective inhibitor. Diabetes 1997; 46: 1473–1480.
   PubMed Web of Science ®Google Scholar
• Hotta N., Nakamura J., Sakakibara F., Hamada Y., Hara T., Mori K., Nakashima E., Sasaki H., Kasama N., Inukai S., Koh N. Electroretinogram in sucrose‐fed diabetic rats treated with an aldose reductase inhibitor or an anticoagulant. Amer J Physiol 1997; 273: E965–971.
   Google Scholar
• Bursell SE, Takagi C., Clermont AC, Takagi H., Mori F., Ishii H., King GL. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats. Invest Ophthalmol Vis Sci 1997; 38: 2711–2720.
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Jirousek MR, Stramm L., Farid N., Engerman RL, Kern TS. Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases. Diabetes 1998; 47: 464–469.
   PubMed Web of Science ®Google Scholar
• Ishii H., Koya D., King GL. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med 1998; 76: 21–31.
   PubMed Web of Science ®Google Scholar
• do Carmo A., Lopes C., Santos M., Proenca R., Cunha vaz J., Carvalho AP. Nitric oxide synthase activity and L arginine metabolism in the retinas from streptozotocin induced diabetic rats. Gen Pharmacol 1998; 30: 319–324.
   PubMedGoogle Scholar
• Sorokin EL, Smoliakova GP. [Structural and functional disorders of transcapillary metabolism if retina in patients with diabetic retinopathy.. Vestn Oftalmol 1997; 113: 16–19.
   Google Scholar
• Lieth E., Barber AJ, Xu B., Dice C., Ratz MJ, Tanase D., Strother JM. Glial reactivity and impaired glutamate metabolism in short‐term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes 1998; 47: 815–820.
   PubMed Web of Science ®Google Scholar
• Gorio A., Donadoni ML, Finco C., Di Giulio AM. Endogenous mono‐ADP‐ribosylation in retina and peripheral nervous system. Effects of diabetes. Adv Exp Med Biol 1997; 419: 289–295.
   Web of Science ®Google Scholar
• Hatcher HC, Ma JX, Chao J., Chao L. Ottlecz A. Kallikrein‐binding protein levels are reduced in the retinas of streptozotocin‐induced diabetic rats. Invest Ophthalmol Vis Sci 1997; 38: 658–664.
   Web of Science ®Google Scholar
• Fang C., Jiang Z., Tomlinson DR. Expression of constitutive cyclo‐oxygenase (COX‐1) in rats with streptozotocin‐induced diabetes, effects of treatment with evening primrose oil or an aldose reductase inhibitor on COX‐1 mRNA levels. Prostaglandins Leukot Essent Fatty Acids 1997; 56: 157–163.
   Web of Science ®Google Scholar
• Linsenmeier RA, Braun RD, Mcripley MA, Padnick LB, Ahmed J., Hatchell DL, Mcleod DS, Lutty GA. Retinal hypoxia in long‐term diabetic cats. Invest Ophthalmol Vis Sci 1998; 39: 1647–1657.
   PubMed Web of Science ®Google Scholar
• Miyamoto K., Hiroshiba N., Tsujikawa A., Ogura Y. In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. Invest Ophthalmol Vis Sci 1998; 39: 2190–2194.
   PubMed Web of Science ®Google Scholar
• Chakravarthy U., Hayes RG, Stitt AW, Douglas A. Endothelin expression in ocular tissues of diabetic and insulin‐treated rats. Invest Ophthalmol Vis Sci 1997; 38: 2144–2151.
   PubMed Web of Science ®Google Scholar
• Chakrabarti S., Gan XT, Merry A., Karmazyn M., Sima AA. Augmented retinal endothelin‐1, endothelin‐3, endothelin A and endothelin B gene expression in chronic diabetes. Curr Eye Res 1998; 17: 301–307.
   PubMed Web of Science ®Google Scholar
• Biro K., Palhalmi J., Toth AJ, Kukorelli T. Bimoclomol improves early electrophysiological signs of retinopathy in diabetic rats. Juhasz G Neuroreport 1998; 9: 2029–2033.
   PubMed Web of Science ®Google Scholar
• De la Cruz JP., Moreno A., Munoz M., Garcia campos JM, de la Cuesta Sanchez F. Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus. J Pharmacol Exp Ther 1997; 280:454–459.
   Web of Science ®Google Scholar
• Barber AJ, Lieth E., Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998; 102: 783–791.
   PubMed Web of Science ®Google Scholar
• Yargicoglu P., Agar A., Edremitlioglu M., Kara C. The effects of cadmium and experimental diabetes on VEP spectral data and lipid peroxidation. Int J Neurosci 1998; 93: 63–74.
   PubMed Web of Science ®Google Scholar
• Jalli PY, Hellstedt TJ. Early versus late staining of microaneurysms in fluorescein angiography. Immonen IJ Retina 1997; 17: 211–215.
   Web of Science ®Google Scholar
• Diamond JP, Mckinnon M., Barry C., Geary D., Mcallister IL, House P., Constable IJ. Non‐mydriatic fundus photography: a viable alternative to fundoscopy for identification of diabetic retinopathy in an Aboriginal population in rural Western Australia? Aust NZ J Ophthalmol 1998; 26: 109–115.
   PubMedGoogle Scholar
• Harper CA, Livingston PM, Wood C., Jin C., Lee SJ, Keeffe JE, Mccarty CA, Taylor HR. Screening for diabetic retinopathy using a non‐mydriatic retinal camera in rural Victoria. Aust N ZJ Ophthalmol 1998; 26: 117–121.
   PubMedGoogle Scholar
• Hernaez ortega MC., Soto pedre E., Vazquez JA, Gutierrez MA. [Study of the efficiency of a non‐mydriatic retinal camera in the diagnosis of diabetic retinopathy.. Asua J Rev Clin Esp 1998; 198: 194–199.
   Web of Science ®Google Scholar
• Shirao Y., Kawasaki K. Electrical responses from diabetic retina. Prog Retin Eye Res 1998; 17: 59–76.
   PubMed Web of Science ®Google Scholar
• Palmowski AM, Sutter EE, Bearse MA Jr, Fung W. Mapping of retinal function in diabetic retinopathy using the multifocal electroretinogram. Invest Ophthalmol Vis Sci 1997; 38: 2586–2596.
   PubMed Web of Science ®Google Scholar
• Kim SH, Lee SH, Bae JY, Cho JH, Kang YS. Electroretinographic evaluation in adult diabetics. Doc Ophthalmol 199798; 94: 201–213.
   Web of Science ®Google Scholar
• Zambarakji HJ, Amoaku WM, Vernon SA. Volumetric analysis of early macular edema with the Heidelberg Retina Tomograph in diabetic retinopathy. Ophthalmology 1998; 105: 1051–1059.
   Web of Science ®Google Scholar
• Asrani S., Zeimer R., Goldberg MF, Zou S. Application of rapid scanning retinal thickness analysis in retinal diseases. Ophthalmology 1997; 104: 1145–1151.
   Web of Science ®Google Scholar
• Hee MR, Puliafito CA, Duker JS, Reichel E., Coker JG, Wilkins JR, Schuman JS, Swanson EA, Fujimoto JG. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998; 105: 360–370.
   PubMed Web of Science ®Google Scholar
• Manfre L., Midiri M., Giuffre G., Mangiameli A., Cardella G., Ponte F., De Maria M., Lagalla R. Blood ocular barrier damage: use of contrast‐enhanced MRI. Eur Radiol 1997; 7: 110–114.
   Web of Science ®Google Scholar
• Hee MR, Puliafito CA, Duker JS, Reichel E., Coker JG, Wilkins JR, Schuman JS, Swanson EA, Fujimoto JG. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998; 105: 360–370.
   PubMed Web of Science ®Google Scholar
• Augsten R., Konigsdorffer E., Schweitzer D., Strobel J. Multisubstance analysis of reflection spectra before and after laser photocoagulation for proliferative diabetic retinopathy. Eur J Ophthalmol 1997; 7: 317–321.
   Google Scholar
• Quigley M., Cohen S. A new pressure attenuation index to evaluate retinal circulation. Arch Ophthalmol 1999; 117: 84–89.
   PubMedGoogle Scholar
• Colangelo L., Mancini A., Lobefalo L., Attimonelli P., Zuppardi E., Falconio G., Mastropasqua L. Echobiometry of the ocular layers at the posterior pole. Ophthalmologica 1998; 212 (suppl 1): 27–29.
   Google Scholar